XTLB — XTL BIOPHARMACEUTICALS LTD
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1023549 ·
Last close
$2.91
Market Cap
$7.15M
52W High
$4.87
52W Low
$2.01
ADV30
140,004
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 166,000 | 76,000 | 420,000 |
| Jun 2025 | — | — | — | — | 714,000 | 150,000 | 761,000 |
| Dec 2024 | 289,000 | -43,000 | -812,000 | -255,000 | 8,550,000 | 371,000 | 3,115,000 |
| Sep 2024 | 162,000 | — | -764,000 | -553,000 | 9,280,000 | 820,000 | 3,563,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-159,009,000
Inventory
—
Receivables
$150,000
ST Investments
$772,000
EBIT TTM
$-939,000
Pretax Income TTM
$-938,000
Interest Exp TTM
$-1,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$968,000
EBITDA
$-1,266,000
Free Cash Flow
$-2,116,000
Enterprise Value
$7,026,069
Total Cash
$76,000
Total Debt
$0
Shares Out
2,457,463
Trailing EPS
$-0.36
Book Value
$0.00
ROE
-29.3%
ROA
-21.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,380,000 | -6,969,000 | 166,000 | 420,000 | — | -1,025,000 |
| Dec 2024 | 451,000 | -2,172,000 | -1,027,000 | 8,550,000 | 3,115,000 | — | -1,618,000 |
| Dec 2023 | 0 | -765,000 | -1,782,000 | 2,426,000 | 206,000 | — | -707,000 |
| Dec 2022 | 0 | -880,000 | -1,348,000 | 4,186,000 | 187,000 | — | -901,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NXTC | NextCure, Inc. | $7.12M | $1.97 | — |
| AVCRF | Avricore Health Inc. | $7.08M | $0.06 | — |
| ERNA | Ernexa Therapeutics Inc. | $7.07M | $6.06 | — |
| BOLT | Bolt Biotherapeutics, Inc. | $7.26M | $3.78 | — |
| HCWB | HCW Biologics Inc. | $7.27M | $4.55 | — |
News headlines (Yahoo Finance, 1h cache)
XTL Completed the Acquisition of Psyga Bio Ltd.
2026-06-30 21:15 · Yahoo
XTL Announces Receipt of Staff Delist Determination from Nasdaq
2026-05-22 20:10 · Yahoo
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologi
2026-04-29 12:58 · Yahoo
XTL Biopharmaceuticals Announces ADS Ratio Change
2026-03-20 20:10 · Yahoo
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
2026-02-27 21:30 · Yahoo
XTL Update on Recent Developments
2026-01-29 21:05 · Yahoo
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
2026-01-23 21:10 · Yahoo
Top Midday Gainers
2026-01-13 18:54 · Yahoo
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
2026-01-13 14:28 · Yahoo
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
2026-01-13 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.